Development of tunable DNA-based material technology
Development of tunable DNA-based material technology
批准号:
10633159
负责人:
Josephine Allen
金额:
$22.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-06-06 至 2025-05-31
关键词:
3-DimensionalAddressAgonistArchitectureBehaviorBindingBiochemistryBiocompatible MaterialsBiologicalBiological ProcessBiological ProductsBiomedical ResearchCell CommunicationCell Culture SystemCell Culture TechniquesCell modelCell physiologyCellsChemicalsChemistryCollagenCollagen Type ICommunitiesComplexCultured CellsDNADNA LibraryDataDevelopmentDiseaseEnvironmentExtracellular MatrixExtracellular Matrix ProteinsFiberFibrosisFunctional disorderFutureGoalsHealthHumanHydrogelsIn VitroInflammatoryMechanicsModelingNamesNecrosisNormal CellPharmacology StudyPhenotypeProcessPropertyPublishingReactionReproducibilityResearchResearch PersonnelResearch Project GrantsShapesSignal TransductionSingle-Stranded DNASiteSystemTechnologyTestingTissuesTranslationsWorkaptamerbiomaterial compatibilitycatalystcell behaviorcell growthcell typechemical conjugatedesignhigh rewardhigh riskin vivoinnovationinsightmechanical propertiespharmacologicprototypereceptorresponseself assemblystem cell differentiationstem cellstechnology developmentthree dimensional cell culturevalidation studies
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Within the biomedical field there is great effort to study a multitude of cell processes, including cell-cell
communication, cell-matrix interactions, cell signaling, pharmacological effects, and differentiation to name a
few. It is widely known that the more closely the cell culture system replicates the native cellular environment,
the more closely the cultured cells will model their native behaviors. Knowing this, over the years, various forms
of three-dimensional culture strategies have emerged as a superior advancement over 2D culture. The most
promising approaches include those that mimic the native extracellular matrix, in its architecture, mechanics,
and composition, thereby providing the ideal biological signaling and cellular recognition sites that promote
normal cell behavior. Towards this goal, the focus of this technology development proposal is to develop a
tunable, bioactive, DNA-based hydrogel platform that can meet these tissue specific requirements and serves to
advance in vitro cell culture. This material technology is significant because the DNA-based hydrogel platform
eliminates the need for complex chemical interactions and takes advantage of the rapid self-assembly and
spontaneous fibril formation that occurs when DNA is complexed with ECM protein collagen. In addition, this
platform utilizes functional DNA aptamers to render the hydrogel bioactive. This technology is poised to promote
cellular functions that are more native and reproducible to a broad community of biomedical researchers. To
achieve our goals, the aims of our project are 1) Examine to bulk material properties achievable with DNA-
collagen based hydrogels; and 2) Functionalize DNA-hydrogels with bioactive DNA aptamers. Our studies will
be compared to commonly used hydrogels and we will demonstrate biological impact through validation studies.
Completion of the above-described aims is expected to reveal the full breadth and potential of DNA-collagen
based materials to mimic tissue specific ECM and serve as a material platform for a broad array of biomedical
studies. We intend to develop a library of DNA-collagen bulk matrix with well-defined synthesis conditions
capable of tunable mechanical properties and bioactivity for a range of cell responses involved cell-cell
interactions, cell-matrix interactions, pharmacological studies, modelled health or disease states of cells,
mechanistic insight into varied cell phenotypes, stem cell studies, and an array of other fundamental studies of
tissue specific cell behaviors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of tunable DNA-based material technology
-
批准号:10430768
-
项目类别:
-
资助金额:$19.06万
-
财政年份:2022
-
负责人:Josephine Allen
-
依托单位:
Nanocomposite drug eluting stents for inhibition of restenosis and thrombosis
-
批准号:9010458
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2016
-
负责人:Josephine Allen
-
依托单位:
Nanocomposite drug eluting stents for inhibition of restenosis and thrombosis
-
批准号:9217674
-
项目类别:
-
资助金额:$36.31万
-
财政年份:2016
-
负责人:Josephine Allen
-
依托单位:
海外基金